Digital Pathology Market Growth Set to Surge Significantly to 2030

Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals), and region (North America, Europe, Asia-Pacific, Middle

A new Report by Delvens, titled "Digital Pathology Market” offers a comprehensive analysis of the industry, which comprises insights on the Global analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.

The global Digital Pathology Market size is 799.296 million USD in 2022 and is projected to reach a CAGR of 8.6% from 2023-2030.

Get Free Sample Report: https://www.delvens.com/get-free-sample/digital-pathology-market

Digital pathology is a computer-enabled, image-based information platform that helps the management of information generated from digital slides. Digital pathology technology can aid a research pipeline in two ways. The first one is that the specified file storage and viewing applications may be used to arrange macroscopic images, tissue microarrays, and entire slide images. The second application of digital pathology in research is the development and implementation of image analysis techniques.

Growth of the global digital pathology market is majorly driven by the increase in the prevalence of cancer; a rise in the demand for accurate diagnostics, and the development of new digital pathology systems by a large number of key players. According to a report published by Medscape, chronic diseases can be associated with a higher mortality rate. The fundamental cause for the development of advanced diagnostic solutions is the rise prevalence of cardiovascular disorders.

Competitive Landscape

  • 3DHistech Ltd
  • Danaher Corporation
  • Glencoe Software Inc.
  • HAMAMATSU Photonics K.K
  • Indica Labs Inc.
  • Koninklijke Philips N.V
  • Nikon Corporation
  • Perkinelmer Inc.
  • Roche
  • VisoPharma A/S.

For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/digital-pathology-market

The Report helps to identify the opportunities in Global Regions:

  • North America (the United States, Canada, and Mexico)
  • Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
  • South America (Brazil etc.)
  • The Middle East and Africa (North Africa and GCC Countries)

Key Findings:

  • The scanners segment is further segmented into Scanners, Software, and Storage systems. The scanners segment is expected to hold the highest orientation during the forecast period.
  • The type segment is further segmented into Human Pathology and Veterinary Pathology. The human pathology segment is anticipated to hold the largest share during the forecast period.
  • The application segment is further fragmented into Drug Discovery, Disease Diagnosis, and Training Education.

Recent Developments

  • In September 2021, Visiopharm (Denmark) and Agilent Technologies, Inc. (US) collaborated to co-market Visiopharm’s portfolio of CE-IVD marked AI-driven Precision Pathology software and Agilent’s automated pathology staining solutions portfolio.
  • In August 2021, Sectra AB (Sweden) and University Medical Center Utrecht (Netherlands) signed an agreement under which UMC uses Sectra’s pathology module for effective multidisciplinary discussions among pathologists and radiologists.

Access Full Report: https://www.delvens.com/report/digital-pathology-market

In addition to the market data for Digital Pathology Market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement.

More Reports From Delvens:

Digital Pharmacy Market size is 96.5 billion USD in 2022 and is projected to reach a CAGR of 18.9% from 2023-2030.

Functional Service Provider (FSP) Market size is projected to reach a CAGR of 8.7% from 2023-2030.

Hormone Replacement Therapy (HRT) Market size is projected to reach a CAGR of 6.3% from 2023-2030.

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT Telecom, Chemicals Materials, Semiconductor Electronics, Energy, Pharmaceutical, Consumer Goods Services, Food Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-3290-6466

+1 214-377-1144

sales@delvens.com


Mayuri Puranik

196 Blog posts

Comments